Compare NTHI & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTHI | CHMI |
|---|---|---|
| Founded | 2008 | 2012 |
| Country | United States | United States |
| Employees | 5 | 14 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.6M | 95.5M |
| IPO Year | N/A | N/A |
| Metric | NTHI | CHMI |
|---|---|---|
| Price | $3.44 | $2.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $15.00 | $3.00 |
| AVG Volume (30 Days) | 65.4K | ★ 174.0K |
| Earning Date | 05-19-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 15.09% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $61.13 |
| P/E Ratio | ★ N/A | $139.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.01 | $2.17 |
| 52 Week High | $12.99 | $3.04 |
| Indicator | NTHI | CHMI |
|---|---|---|
| Relative Strength Index (RSI) | 35.86 | 39.29 |
| Support Level | $3.01 | $2.17 |
| Resistance Level | $4.59 | $2.46 |
| Average True Range (ATR) | 0.38 | 0.05 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 25.55 | 13.10 |
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.